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ABSTRACT
Yerrapragada, Sri Meghana. M.S. Department of Pharmacology and Toxicology, Wright State
University, 2021. The Protective Effects of miR-210 Modified Endothelial Progenitor Cells
Released Exosomes in Hypoxia/Reoxygenation Injured Neurons.
Endothelial progenitor cells (EPCs) have been shown to provide beneficial effects on oxidative
stress. Exosomes (EXs) released from these stem cells could be one of the major contributors, as
they are known to convey the benefit of one cell to another cell via microRNAs (miRNA). At first,
we determined that EPCs release more EXs when they are serum-starved for 48 hours., and by
determining the microRNA-210 (miR-210) levels in the EXs, we found that miRNA is being
transferred from cells to EXs. Meanwhile, miR-210 is gaining popularity in reducing elevated
oxidative stress levels. In this study, we investigated the role of endothelial progenitor cells-EXs
(EPC-EXs) and the beneficial effects of loading miR-210 into EPC-EXs (miR-210-EPC-EXs) on
hypoxia and reoxygenation (H/R) induced reactive oxygen species (ROS) overproduction,
apoptosis, and reduced viability of neuronal cells. It was found that EXs were uptaken by neurons
and elevated the miR-210 levels in the neurons. In comparison with the vehicle, the EPC-EXs and
EXs from scramble transfected EPCs (Scramble-EPC-EXs), were efficient in attenuating neuronal
apoptosis, elevated oxidative stress, and restoring cell viability. Whereas the miR-210-EPC-EXs
were more efficient in attenuating these inimical effects induced by H/R injury in neurons.
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I.

INTRODUCTION

1. Ischemic Stroke
1.1. Definition, pathophysiology, types, and symptoms
The brain requires oxygen and nutrients to carry out its functions, and blood supplies these required
nutrients and oxygen to the brain and removes cellular waste and carbon dioxide from the brain
[1]. Cerebrovascular disruption in the blood supply to the brain is known as stroke, this can be
caused by a blockage in a blood vessel or because of blood vessel rupturing which are referred to
as Ischemic stroke and Hemorrhagic stroke, respectively [2].
The word Ischemia is derived from the Greek language, ‘Ischaimos’ means-to restrain, and ‘haima’
means blood [3]. Ischemia occurs when there is an obstruction in the flow of blood to the brain.
The reduction in blood supply to the brain is due to thrombotic or embolic events [4]. Either
because of atherosclerosis, arterial dysfunction, or vasculitis, a clot(thrombus) is formed in blood
vessels and so blood supply to certain regions of the brain is decreased, and this is referred to as
thrombosis. In embolic events, an obstructing material(embolus) from different regions of the body
is dislodged because of blood current and finally creates a block in the artery [5]. Mostly the
obstructing material is clot but it may also be an air bubble, tissue piece, fat globule, or a bacterial
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clump

[4].

Fig 1: Ischemic Stroke: The clot formation in the cerebral blood vessel interrupts the blood supply to the brain thus
creating a hypoxic condition in the brain [13].

The TOAST classification (Trial Org10172 in Acute Stroke Treatment) categories the ischemic
stroke into Cardio embolism, Small vessel-occlusion, Large-artery atherosclerosis, and stroke of
undetermined etiology [1].
When the blood supply to certain regions of the brain is decreased then we tend to observe certain
signs and symptoms and basing on these symptoms, clinicians would recognize the area of clot
formation [3].
Infracted Area
Anterior Cerebral Artery Infarction

Clinical presentation
• In the lower extremity reduction in contralateral sensory
and motor functions is observed [6,7].
• In left-sided lesions, more transcortical motor aphasia is
seen. Whereas acute confusion state and motor
hemineglect are seen in right-sided lesions [7].
2

Middle Cerebral Artery Infarction

Posterior Cerebral Artery Infraction

Vertebrobasilar Infarction

Cerebellar Infarction

Lacunar Infarction

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Contralateral hemiparesis, facial paralysis [3].
An abnormality in a gaze towards the side of the lesion
may be observed [3].
Dysarthria.
Aphasia.
Ataxia.
Hypoesthesia.
Hypersomnolence.
Cognitive deficits.
Ocular findings (homonymous hemianopsia).
Impaired tactile sensation, stereognosis.
Loss of awareness of position and movement of the body.
Rarely cortical blindness and amnesia are observed.
unilateral headache is commonly observed.
Ataxia
Abnormal oculomotor findings
Vertigo
Vomiting
Visual field deficit
Oropharyngeal dysfunction
Headache
Ataxia
Dysarthria
Edema
Headache
Nausea
Vomiting, symptoms of vertigo
Ataxic hemiparesis
Motor/Sensory loss

Table 1: Signs and symptoms corresponding with the area of the brain being affected [6,7,8,9].

1.2. Effect of ischemic stroke on neurons:
For proper functioning of the brain, neurons require a sufficient amount of glucose and oxygen
[10]. These glucose and oxygen are utilized by the brain to generate ATP and to maintain
membrane potential. Neurons communicate with each other through electrical activity and for
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proper electrical signaling the resting membrane potential has to be maintained [3]. This in
turn is ATP dependent, where three sodium ions are expelled out and intake of two potassium
causes unequal positive charge distribution across the membrane and creating a -70-mV
charge. During ischemic stroke, the artery that supplies blood to the brain is blocked and so
the neurons are deprived of oxygen, which is referred to as hypoxia [11]. This low oxygen and
glucose condition results in ATP level depletion, which causes depolarization of resting
membrane potential. Then neurons start firing the action potential to the synapse and releases
the neurotransmitter glutamate [10,11].

4

Fig 2: Hypoxia causing excitotoxicity in neurons [14].
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During normoxia, this glutamate is up taken from the synapse by Excitatory Amino Acid
Transporter 2(EAAT 2) which is located on astrocytes. During hypoxia conditions because of
low ATP levels, these transporters fail to work, as a result, a high concentration of glutamate
is available at the synapse [15]. The glutamate binds to glutaminergic receptors (NMDA-R and
AMPA-R) and rises intracellular calcium levels. High intracellular calcium causes
mitochondrial injury and free radicle formation. Which leads to injury to the nucleus, cell
membrane, and finally neuronal death. Besides this, it is also observed that certain proinflammatory cytokines like IL-1β (interleukin-1beta) and TNF-α (tumor necrosis factoralpha) release causing edema and cell death [15].

1.3. Epidemiology:
Annually 15 million people throughout the world suffer from stroke, 5 million people from this
population are being disabled for a lifetime and other 5 million people are losing their life. In the
USA, each year about 795,000 Americans are suffering from stroke, among these ~610,000 are
first attacks and 185,000 are recurrent attacks [12,16]. According to the Northern Manhattan Study,
blacks, and Hispanics experience higher ischemic stroke incidences in comparison with whites,
and the risk of all types of strokes is low in men, contrastingly the life expectancy of women is
higher than men [16].
1.4. Risk factors:
•

Major risk factors include:

•

Age: All age groups are susceptible to ischemic stroke but infants below the age of 1 and
adults are at higher risk.
6

•

Arteriovenous malformations: This is also referred to as an aneurysm, it is a balloon-like
bulge in blood vessels.

•

Cardiovascular diseases: These include atrial fibrillation, carotid artery disease, coronary
heart disease, and heart valve disease. These conditions can create blockages and clots in
the blood vessels that supply blood to the brain.

•

Diabetes: This is a condition in which glucose levels in the blood are high, over a period
of time these high glucose levels in the blood can cause cardiovascular diseases, kidney
disease, nerve damage, kidney problems, and retina damage.

•

Genetics and family history: Genes that determine your blood group can affect the stroke
risk, people with AB blood group are at greater risk of developing a stroke. We are more
prone to stroke if one of our parents or close family members has a past history of stroke.

•

High LDL cholesterol levels

•

High blood pressure

•

Inflammatory conditions/viral infections: like SARS-Cov-2, lupus may raise the risk of
developing a stroke.

•

Overweight and Obesity

•

Race and ethnicity: In comparison with whites adults, African Americans, Hispanics,
Chinese and American Indians are more prone to stroke.

•

Sex: Between men and women, women are more prone to stroke. Women under hormone
replacement therapy and women during the pregnancy phase have a higher risk of stroke.
At a younger age than women men are more likely to have a stroke [3,17].

•

Smoking
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Fig 3: Stroke statistics: Gender differences in stroke among elderly people [18].

➢ Other risk factors:
•

Unhealthy lifestyle: excess alcohol, and drug consumption, irregular sleep cycle,
overeating, and lack of physical activity.

•

Anxiety, depression and, stress.

•

Living in a polluted environment.

•

Other medical conditions: like sleep apnea, kidney disorders, sickle cell disease, bleeding
disorders, and excess usage of blood thinners [17].

1.5. Diagnostic methods:

To evaluate the severity of the stroke and to plan the treatment physician would primarily perform
a physical examination. With the help of a stethoscope, he will listen to the carotid artery blood
8

flow. If a whooshing sound is detected, then this indicates abnormal blood flow in the carotid
artery, this might be because of plaque formation [19]. The physician would also cross-check
patience alertness, balance, coordination, the flow of speech, and numbness in arms legs, and face.
Diagnostic tests include:
•

CT (computed tomography)-scan: When a stroke is suspected this specific test is
performed, this will give us clear pictures of the brain, detects if there exist any bleeding
and damage in the brain [19].

•

MRI (magnetic resonance imaging): After a CT scan this test helps in detecting the
area and extent of brain tissue damage and enables physician in diagnosing the type of
stroke [19].

•

Spinal tap/lumbar puncture: This test is performed by collecting fluid from the spine
and examined it for the presence of any substances from ruptured blood cells. If the
physician is suspecting a hemorrhagic stroke and no bleeding is detected in the CT
scan, then he/she would suggest the patient go through this test [19,20].

•

ECG (Electrocardiogram): As cardiovascular diseases are one of the main risk
factors of stroke, this test helps in detecting cardiac abnormalities like heart attacks and
atrial fibrillation.

•

Imaging and blood tests: In case of aneurysm or blood vessels narrowing in both neck
and brain these tests are suggested [20]. Blood test helps in providing information
regarding platelet count, clotting time, muscle damage and blood glucose levels
[19,20].
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1.6.Treatment

Clot removal is the main goal of ischemic stroke treatment, this can be achieved by medication
and mechanical treatments. According to American Stroke Association (ASA) and American
Heart Association (AHA) tissue Plasminogen Activator (tPA)is considered to be the most effective
treatment for stroke [21]. It is a protease usually found in endothelial cells; this enzyme plays a
catalytic role in the conversion of plasminogen to plasmin. Alteplase, Reteplase, and Tenecteplase
are the three commercially available tPAs, these are produced by recombinant biotechnology
techniques (rtPA) [24]. FDA has approved Alteplase and Reteplase for the treatment of ischemic
stroke, myocardial infarction, and pulmonary embolism. tPA has to be administered to the
ischemic stroke patient within 4 ½ half hours from the onset of stroke [23,24].

Mechanism of action of rtPA:

•

rtPA has a low affinity to free plasminogen present in plasma but has a high affinity towards
plasminogen that is bound to fibrin in a clot. It binds to the clot which is rich in fibrin
through Kringle 2 domain and fibronectin finger-like domain. As tPA is a protease, it
converts plasminogen to plasmin by cleaving Arg/Val bond. The plasmin thus formed starts
degrading the clot’s fibrin matrix. As a result, a thrombolytic effect is produced [24].
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Fig 4: Mechanism of action of tPA: tPA activates plasminogen bound to fibrin in a clot and forms plasmin as a
result clot gets dissolved [25].

tPAs are contraindicated in the following conditions:
•

The onset of stroke exceeds more than 5 hours after time.

•

Recent head injury/brain surgery to the patient.

•

Bleeding in the brain.

•

If a patient is on anticoagulant treatment.

The tPAs have very brief half-life, for example Alteplase has 5 minutes and Reteplase has 20 mins.
The advantage of this is they disintegrate the clot and gets eliminated from the body very quickly
and the disadvantage is increased chances of re-occlusion [25]. In case if tPA treatment does not
go well with the patient then mechanical treatments like thrombectomy, angioplasty, and stenting
procedures, and stem cells therapy are good options in removing the blockage in the blood flow to
the brain [24,25].
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2. Endothelial Progenitor Cells (EPCs)
2.1. History and Origin:
Until the late 90’s there is no proper information regarding endothelial progenitor cells (EPCs). In
the year 1997, Ashara et.al. first discovered endothelial progenitor cells (EPCs) and published a
paper on the isolation of putative progenitor endothelial cells for angiogenesis [26]. They have
described peripheral blood mononuclear cells which can differentiate into endothelial cells (ECs).
They have observed that these ECs express hematopoietic stem cells marker i.e., CD34, and a
bunch of different markers which are later discovered to identify these cells. In adults, EPCs are
mainly formed in the bone marrow but they are also found in peripheral blood, umbilical cord
blood, and fetal liver [27]. These are a kind of stem cells which has high proliferation potency and
involve in neovascularization by undergoing differentiation into mature endothelial cells.

Factors increasing the circulating EPCs count

Factors decreasing the circulating EPCs count

Estrogen
Erythropoietin
VEGF
Stromal cell–derived factor-1
Physical training

Diabetes
Tobacco smoking
vascular diseases

Table 2: Factors modulating circulating EPCs count [28].

EPCs from different origins express different markers. For example, CD133+/CD34+/VEGFR-2+/
are expressed by the bone marrow EPCs which are immature in nature. EPCs from peripheral
blood are mature, early peripheral blood derived EPCs express CD133+−/CD34+/VEGFR2+/CD31+/CD146+/VE-cadherin−/eNOS−/vWF

and

CD133−/CD34+/VEGFR-

2+/CD31+/CD146+/VE-cadherin+/eNOS+/vWF+ markers are expressed by late peripheral blood
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derived EPCs. Whereas mature ECs express VEGFR-2, CD31, CD146, VE-Cadherin, endothelial
nitric oxide synthase (eNOS), and von Willebrand factor (vWF) [26,27,28].

Fig 5: Markers expressed by different types of EPCs. Bone marrow EPCs are identified by the markers CD133,
CD134, VEGFR-2, Circulating EPCs express CD133, CD34, VEGFR-2, CD146 and C3. VEGFR-2, CD31, CD146,
VE-Cadherin, eNOS and vWF [28].

2.2.Functions and their role in ischemic stroke.
After Ischemic injury, EPCs protect the neurovascular system by repairing secretory functions and
vascular endothelium. Besides these re-endothelialisation and neovascularization functions, they
are also known for their angiogenesis, wound healing ability, and tissue regeneration [29].
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Fig 6: Functions of EPCs [29].

3. Exosomes.
3.1 Discovery, Introduction, and Composition.

In the year 1946 first study regarding Extracellular Vesicles (EVs) has been published. Until
the 1980s these were considered as cellular wastes or dust particles that are budded from the
plasma membrane of all living cells, later their role in cellular communication has been
unveiled [30]. Exosomes are the smallest EVs whose diameter ranges from 30-150 nm. These
have been named exosomes by Rose Johnstone as they are formed by fusion and exocytosis of
multivesicular bodies to the plasma membrane [30,31]. These are enveloped by two layers of
lipid and the vacuole usually comprises mRNA, miRNA, DNA, lipids, proteins, and some
components from the golgi apparatus, mitochondria, endoplasmic reticulum, and nucleus.
They contain biomarkers like Ras-related protein Rab-11B, CD63, CD81, charged
multivesicular body protein 2a, and TSG101proteins and lipids like ceramide, cholesterol,
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phosphatidylserine, and sphingomyelin [33]. The composition of exosomes depends on the
type of cells they are originated from, and they highly influence cellular functions [32,33].

Fig 7: Extracellular vesicles. Exosomes are the smallest MVs size ranging from 30-150 nm, followed by Micro
Vesicles (MVs) in the size 100-1000nm, and apoptotic bodies being the largest in the size 100-5000 nm.

These are found in almost all body fluids like amniotic fluid, breast milk, bronchial fluid, bile,
cerebral spinal fluid (CSF), gastric acid, lymph, plasma, saliva, semen, synovial fluid, tears, and
urine [31].

3.2 Biogenesis.
Exosome biogenesis is a highly regulated process that is initiated by the inward budding of
endosomes, this results in the formation of Multi-Vesicular Endosomes (MVEs), that have intraLuminal Vesicles (ILVs) [33]. The exosomes are released into the extracellular space when MVEs
fuse with the plasma membrane and release the ILVs [34]. They communicate with other cells by
docking and fusing. Endosomal Sorting Complex Required for Transport (ESCRT) and Nethylmaleimide-sensitive factor attachment protein receptor (SNAREs) complexes play a key role
in exosomes synthesis as well as docking and fusing of exosomes with other cells in the process
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of cell-to-cell communication [35]. Sorting of cargos into exosomes and its biogenesis can also
occur even without depending on ESCRT. Besides SNAREs and ESCRT, there are several lipids
like ceramides and proteins like annexins, flotillins, GTPases, heat shock proteins, lactadherin,
platelet-derived growth factor receptors, and Tetraspanins which have an important role in the
biogenesis

of

exosomes

[34,35,36].

Fig 8: Exosome biogenesis [37].

3.3 Isolation and characterization techniques.
Exosomes can be isolated by different methods; ultracentrifugation is the most popular method,
where exosomes are isolated by high-speed centrifugation. Besides this, they are isolated through
size-based filtration, size exclusion chromatography, purification through immune affinity,
polymer precipitation, and microfluidics isolation techniques [34,36,37].
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Fig 9: Techniques used for exosomes isolation and characterization [37].

Upon isolation to understand their interaction ability with cells, it is important to determine
exosomes size, shape, density, porosity, and charge on the surface. Characterization techniques
include nanoparticle tracking analysis (NTA), Dynamic light scattering (DLS), Atomic force
microscopy (AFM), resistance pulse sensing, electron microscopy, and flow cytometry. NTA is a
widely used biophysical method of characterizing exosomes, by this method we can determine
exosomes size, shape, and concentration. It can measure the particles up to 30nm in size. By
attaching a fluorescent-labeled antibody, we can detect the antigen presence. The most appealing
aspect of this technique is that we can retrieve the original sample even after characterizing the
samples [37].
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3.4 Functions.
Exosomes have a great role in cell-to-cell communication. By examining the miRNA of exosomes,
we can understand the disease's mechanism and so exosomes are not only used as diagnostic
biomarkers but also, they help in developing a potential treatment for those diseases. They are also
found to be involved in generating immune responses, inflammation, coagulation, wound healing,
and angiogenesis. Because of their long circulating half-life and moreover, they do not have a risk
of transplant rejection and aneuploidy, they are being used as the safest therapeutic tools by
modifying their cargoes according to our needs [39]. Exosomes can even cross the blood-brain
barrier, so they can be used in treating neurological disorders. Exosomes derived from a variety of
cell types such as embryonic stem cells, induced pluripotent stem cells (iPSCs), adult stem cells
such as mesenchymal stromal cells (MSCs), human umbilical cord blood cells (HUCBCs), neural
stem cells (NSCs), and endothelial progenitor cells (EPCs) have been employed to treat ischemic
stroke and other cerebrovascular diseases in pre-clinical studies [38].
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Fig 10: Functions of exosomes [39].

3.5 Applications.

According to Wu, Xu, et al., transferring miR-126 to the endothelium through endothelial
exosomes results in down-regulation on sprouty-related EVH1 domain-containing protein 1
(SPRED1) and subsequently promotes RAF/ERK pathway which finally results in an
improvement in endothelial functioning and there by ameliorates the lung injury [40]. In 2016, Li
X. et al. and Zhang J.et al. explicated that EPC-EXs activates Erk1/2 signaling which stimulates
angiogenic activity in ECs by which wound healing is accelerated [41]. Wang, Jinju, et al.,
Recently found that post-stroke inflammation in acute intracerebral hemorrhagic stroke can be
alleviated by infusing ACE-2 through EPC-exosomes [44]. Ma, Xiaotang, et al. in the year 2018
stated that EPC-exosomes loaded with miR-210 can protect endothelial cells from hypoxia and
reoxygenation injury by protecting mitochondrial functionality [48].
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4. MicroRNA-210.
4.1 Definition, location, and targets.
As it is induced in a wide range of cells under hypoxia conditions, miR-210 is considered as
master hypoxamir. In the intron of a non-coding RNA, the stem-loop of miR-210 is situated
and it is transcribed from AK123483 on chromosome 11p15.5. HIF1 alpha and HIF2 alpha
regulate miR-210, apart from this nuclear factor-kB (NFkB) is also responsible for miR-210
induction during hypoxia [43]. It is usually over-expressed in cells affected by tumor and
cardiac

diseases

[43].

Fig 11: miR-210 targets and their biological consequences [43].

4.2 Functions:
By targeting proteins that are important for cell cycle progression miR-210 inhibits cell
proliferation, examples include E2F3 protein, fibroblast growth factor receptor-like 1 (FGFRL1),
homeobox A1 (HOXA1) in cells like human embryonic kidney cells, keratinocytes, and ovarian
cells, miR-210 inhibits cell proliferation. They are known to promote stem cell survival by
20

targeting caspase-8-associated protein 2 (CASP8AP2) or FLICE-associated protein homolog
(FLASH-human homolog). Besides this they are also known to induce angiogenesis, support
differentiation of cells, halt DNA repair, inhibit mitochondrial metabolism., Also miR-210 levels
are elevated in several diseases like head and neck carcinoma, lung cancer, melanoma, and
pancreatic ductal adenocarcinomas and so they can be used for diagnostic purposes. We know that
miR-210 has a huge effect on cell functioning and during pathological conditions, it is either
overexpressed or under-expressed. Correcting this expression would be a new therapeutic
approach for several diseases like tumor progression and ischemic stroke [43].
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II. HYPOTHESIS AND SPECIFIC AIMS
Hypothesis:
Exosomes from miR-210 overexpressed endothelial progenitor cells can protect neurons from
hypoxia/reoxygenation (H/R) - induced injury by reducing neuronal apoptosis and ROS production
and promoting neuronal survival.
Specific aims:
Aim 1) To verify the delivery of miR-210 to the target cells by EPC-EXs.
1a: To confirm that the transfection of miR-210 mimic increases the miR-210 level in both
EPCs and EPC-EXs.
1b: To determine whether miR-210 overexpressed EPC-EXs could be up taken by neurons
and increase the level of miR-210 in neurons after coincubation.
Aim 2) To explore if miR-210 transfection enhances the protection of EPC-EXs on H/R-injured
neurons.
2a: To determine the protective effects of EPC-EXs on oxidative stress and cell viability
in H/R injured neurons.
2b: To explore if miR-210 transfection boosts the beneficial effects of EPC-EXs on
oxidative stress and cell viability in H/R-injured neurons.
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III. EXPERIMENTAL DESIGN
Design for Aim 1a:
EPCs were cultured and allowed to grow until they reach 70-80% confluency, then for the next 48
hours, they were transfected with miR-210 mimic with the aid of Dharmafect 1 transfection
reagent. In order to extract exosomes, the EPCs were subjected to serum starvation for 48 hours,
later the media was collected, and exosomes were isolated by ultra-centrifugation. Meanwhile, the
transfected EPCs are collected by trypsinization followed by centrifugation. RNA was extracted
from both the cells and exosomes using TRIzol reagent. Reverse transcription was performed to
synthesize cDNA from RNA using a PrimeScript RT reagent kit. Then on a real-time PCR
instrument using miR-210 specific primers, qRT-PCR was performed (Fig 12). The miR-210
expression was calculated using the 2−ΔΔCT method and U6 RNA was used as an internal control.
In addition to this to evaluate the effect of stress on EXs release and time course of EXs release
we have cultured EPCs in the presence and absence of serum and measured the EXs
concentrations. For the time-course study we have isolated EXs at 6-, 12-, 24-, and 48-hours’ time
points (post serum starvation). And also, we have quantified the miR-210 levels in EPC and EXs
at these above-mentioned time points and before/after the serum starving the EPCs.
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.

Fig 12: Pictorial representation of AIM 1a

Design for Aim 1b:
EPCs were cultured and allowed to grow until they reach 70-80% confluency, then they were
transfected with miR-210 mimic for 48 hours with the aid of Dharmafect 1 transfection reagent.
The EPCs were subjected to serum starvation for the next 48 hours, later the media was collected,
and exosomes were isolated by ultra-centrifugation. In order to verify whether exosomes are uptaken by neurons or not, the exosomes are labeled with PKH26 a lipophilic-membrane dye that
exhibits red fluorescence. Then they were resuspended in neuronal complete growth media.
Meanwhile, sh-sy5y neuronal cells were grown to 80-90% confluency and in order to induce
hypoxia injury these cells were kept in a hypoxia chamber (with 1% O2, 5% CO2, and 94% N2)
for 6 hours, and later unlabeled EPC-EXs and labeled EPC-EXs were added to their wells and co-
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cultured for 48 hours. Later, fluorescent images were recorded for neurons that are co-cultured
with labeled EXs (Fig 13). And neurons that were co-cultured with un-labeled EXs are processed
for RNA extraction using TRIzol reagent, cDNA was synthesized by reverse transcription. By
using miR-210 specific primers on a real-time instrument qRT-PCR was performed (Fig 13). The
miR-210 expression was calculated using the 2−ΔΔCT method and U6 RNA was used as an
internal control.

Fig 13: Pictorial representation of AIM 1b

Design for Aim 2a:
EPCs were cultured and allowed to grow until they reach 80-90% confluency. The EPCs were
subjected to serum starvation for the next 48 hours, later from this media, exosomes were isolated
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by ultra-centrifugation, and they were resuspended in neuronal serum-free growth media.
Meanwhile, sh-sy5y neuronal cells were grown to 80-90% confluency and these culture plates
were kept in a hypoxia chamber (with 1% O2, 5% CO2, and 94% N2) for 6 hours. Then they were
reoxygenated for 24 hours, during this reoxygenation phase; neurons were co-cultured with EPC
EXs. After co-culturing for 24 hours percent apoptosis, western blot, oxidative stress, cell viability
of neurons were performed, and results were analyzed (Fig 14).

Fig 14: Pictorial representation of AIM 2a and 2b

Design for Aim 2b:
EPCs were cultured and allowed to grow until they reach 70-80% confluency, then they were
transfected with miR-210 mimic for 48 hours with the aid of Dharmafect 1 transfection reagent.
The EPCs were subjected to serum starvation for the next 48 hours, later from this media,
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exosomes were isolated by ultra-centrifugation, and they were resuspended in neuronal serum-free
growth media. Meanwhile, sh-sy5y neuronal cells were grown to 80-90% confluency and these
culture plates were kept in a hypoxia chamber (with 1% O2, 5% CO2, and 94% N2) for 6 hours.
Then they were reoxygenated for 24 hours, during this reoxygenation phase; neurons were cocultured with miR-210 overexpressed EPC EXs. After co-culturing for 24 hours. percent apoptosis,
oxidative stress, cell viability of neurons were performed, and results were analyzed (Fig 14).
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IV. MATERIALS AND METHODS

Materials
Human endothelial progenitor cells and sh-sy5y Human Neuroblastoma cell lines were purchased
from ATCC. Human endothelial progenitor cell culture complete growth media with serum and
antibiotics and human endothelial progenitor cell culture expansion media serum-free with
antibiotics were purchased from Celprogen (Torrance, CA). Culture media for neurons consist of
Eagle’s Minimum Essential medium purchased from Corning cellgro (Manassas, VA), F-12K
Nutrient Mixture, and Fetal Bovine Serum were purchased from Gibco (Co Dublin, Ireland).
Dharmafect 1 from Dharmacon. miR-210 mimic and its negative control are purchased from
Qiagen (Venlo, Netherlands). 0.05% trypsin-EDTA was purchased from Gibco (Co Dublin,
Ireland). MTT reagent (3- [4, 5-dimethylthiazyol-2yl]-2, 5-diphenyltetrazolium bromide), TRIzol
reagent, and PKH26 was purchased from Sigma-Aldrich (St.Louis, MO). Chloroform and 2Propanol are purchased from Fisher scientific. Dihydroethidium was purchased from Invitrogen
(Carlsbad, CA). Propidium iodide (PI) and Annexin V and were purchased from BDbiosciences.

Cell culture
For this study, Human endothelial progenitor cells (HEPCs) and Human Neuroblastoma cell lines
(SH-SY5Y) were used. HEPCs at passages 1-10 were used and they were cultured in HEPC
complete growth medium with serum and antibiotics in an incubator under standard cell culture
conditions (i.e.,37°C and 5% CO2). The culture media was changed on every alternative day. The
SH-SY5Y neuronal cell lines at passages 1-9 were used in this study, and they were grown under
standard culture conditions in a media made up of Eagle’s Minimum Essential Medium and F-12K
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Nutrient Mixture (1:1), FBS (10%), and 5% penicillin/streptomycin (P/S) solution. For every 2
days, the culture media was changed. Both these cell types were usually passaged in a 1:3 ratio,
for sub-culturing, and their respective cell growth media was replaced with 0.05% trypsin-EDTA
for 4 mins at 37°C, later to stop the trypsin action their respective complete growth media with
serum was added. Then the complete solution was collected and centrifuged at 300 x g for 6
minutes, the cell pellet was resuspended using respective culture media.

EXs isolation
To release exosomes from EPCs, EPCs were subjected to serum starvation for 48 hours., then the
media was collected and centrifuged at 300 x g for 6 minutes, later to remove the cell debris the
supernatant was centrifuged at 20,000 x g for 70 minutes, at the end of this step in the form of
pellet; microvesicles (MVs) are obtained. The supernatant from the previous step was collected
and again centrifuged at 170,000 x g for 90 minutes. The exosomes were isolated in the form of a
pellet, the supernatant was removed and with 100μl sterile-filtered phosphate buffer saline (PBS)
the exosomes were resuspended [53].

Nanoparticle tracking analysis (NTA)
NS300 instrument ((Nanosight, Amesbury, UK) utilizes the light scattering and Brownian motion
properties and helps in visualizing and measuring the concentration and size of the isolated
exosomes. It can detect the particles of diameter from 10 nm-2 μm and concentration in the range
107-109 particles/ ml. The isolated exosomes were diluted at a concentration of 107-109 particles/
ml using filtered PBS and then the sample (700 μl) was loaded into the instrument carefully without
creating any air bubble in the frame. Three videos of particle movements were recorded for each
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sample at a rate of 30 frames/second and three different locations. These samples were analyzed
using NTA software (version 2.2, Nanosight). The concentration of particles was calculated by
considering its dilution factor.

EXs labelling
PKH26 is a lipophilic-membrane dye that exhibits red fluorescence and is used to label exosomes.
In the final step of exosomes isolation (ultracentrifugation at 170,000 x g), the exosomes were
obtained as a pellet, and to label them with PKH26 the pellet was resuspended using dye solution
(2 μl PKH26+1 ml PBS) and incubated for 5 minutes. Then to halt the reaction 1ml of 1% BSA
solution was added and kept undisturbed for 1 minute. Later this solution was ultracentrifuged
again at 170,000 x g for 90 minutes. The supernatant was removed, and the labeled exosomal pellet
was resuspended using SH-SY5Y media [42].

Hypoxia and reoxygenation (H/R) injury model for Neurons
Under in-vitro conditions, ischemic stroke in neurons was induced by exposing the neurons to
hypoxia conditions and followed by reoxygenation. Until 80-85% confluency, the neurons were
grown in a complete SH-SY5Y medium, then they were kept in a hypoxia chamber, with 1% O2,
5% CO2, and 94% N2, for 6 hours. After this, the neurons were reoxygenated (37°C and 5% CO2standard incubator conditions) for 24 hours. During the reoxygenation phase exosomes were added
to neurons and co-cultured [45].
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miR-210 transfection
miR-210 was overexpressed in EPCs by transfecting them with miR-210 mimic (10 nm working
concentration) with the aid of Dharmafect 1 transfection reagent, for 48 hours. Then the exosomes
released by these cells tend to have elevated levels of miR-210 in their cargo in comparison with
non-transfected cells and their exosomes.

Co-culturing of EXs with Neurons
Upon isolation of exosomes, all the exosomes (Control EPC-EXs, Scramble EPC-EXs, miR-210
overexpressing EPC-EXs and labeled EPC-EXs) were resuspended with SH-SY5Y medium and
added to cells at a concentration of 3 x 109 EX particles/ml. These exosomes were co-incubated
with neurons for 24 hours [48]. Then the cells were processed for assays or fluorescent imaging.

miR-210 expression analysis
RNA from EPCs, EPC-EXs, and SH-SY5Y neurons (after co-culturing) was extracted by adding
TRIzol reagent (1000 µL for cells, 100 µL for exosomes, and 200 µL for neurons). After adding
TRIzol reagent, it was allowed to sit for 1 minute, this will homogenize the sample and inhibits
RNase activity. Then chloroform (100 µL for cells, 10 µL for exosomes, and 20 µL for neurons)
was added to and allowed to sit for 10 minutes at room temperature and followed by centrifugation
at 12,000 g for 15 minutes at 4-degree C., this step will help RNA to separate from DNA and
proteins. Upon adding chloroform and following centrifugation, an organic phase protein/cell
debris remained at the bottom, DNA stayed as an interface, and the RNA was extracted from the
topmost layer of the aqueous phase. To this, pre-cooled isopropanol (500 µL for cells, 50 µL for
exosomes, and 100 µL for neurons) was added and mixed with the aqueous RNA layer, then it was
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left undisturbed for 10 minutes in -20-degree C., and later subjected to centrifugation at 12,000 g
for 15 minutes. The supernatant was removed, and 75 % pre-cooled ethanol (1 mL for cells, 100
µL for exosomes, and 200 µL for neurons) was added to the pellet and mixed. This was followed
by centrifugation at 7,500 g for 5 minutes at 4-degree C. Later the supernatants were completely
removed, and tubes were air-dried in a ventilation hood for about 10 minutes. The RNA from cells
and exosomes were eluted using RNase-free water (50µL for cells, 10 µL for exosomes, and 20µL
for neurons). The concentration of isolated RNA was determined using Nanodrop 2000. Using
PrimeScript RT reagent kit (Takara Bio Inc.) and by following the manufacturer’s instructions the
RNA was reverse transcribed into cDNA. Then to quantify this cDNA, qRT-PCR was performed
using SYBR Premix Ex Taq kit (Takara Bio Inc.) with miR-210 specific primers on a real-time
PCR instrument (Bio-Rad). U6 was used as internal control and the relative gene expression of
miR-210 was calculated using the 2−ΔΔCT method. The miR-210 mimic gene expression was
compared with control and scramble groups.

Cell apoptosis assay
Apoptosis in SH-SY5Y neuronal cell lines was determined using Annexin V/ PI.
Phosphatidylserine is a phospholipid that under normal conditions present on the inner side of the
plasma membrane and during apoptosis the plasma membrane is scrambled as a result the
phosphatidylserine is exposed out. Annexin V is used as a biomarker for apoptosis as it irreversibly
binds to phosphatidylserine. To determine apoptosis, SH-SY5Y cell lines were cultured in 6-well
plates and injured by subjecting them to hypoxic conditions for 6 hours; the cells were then reoxygenated for 24 hours. During the reoxygenation phase, the neurons were co-cultured with
different EPC-EXs. After co-culturing the cells from different groups were collected separately by
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trypsinization and centrifugation. The cell pellets were resuspended with Annexin V binding buffer
(5 μl) and vortexed. Only to the isotype control isotype PE and APC (5 μl each) were added and
to the remaining groups conjugated PI (10 μl) and Annexin V (5 μl) were added, vortexed and
allowed to sit in dark for 15 minutes at room temperature. Then centrifuged for 6 minutes at 300
x g, discarded the supernatant, and resuspend the labeled cells in Annexin V binding buffer. The
samples were analyzed using a flow cytometer.

Intracellular ROS generation assay
Dihydroethidium staining is an efficient method used to determine intracellular ROS
levels/oxidative stress. DHE is a superoxide indicator, superoxide oxidizes DHE is to 2hydroxyethidium, this will intercalate with DNA and results in staining of cytosol and nucleus into
bright red. To determine oxidative stress inside the neurons, SH-SY5Y cell lines were cultured in
6-well plates and injured by subjecting them to hypoxic conditions for 6 hours. The cells were then
re-oxygenated for 24 hours, and during the reoxygenation phase the neurons are co-cultured with
different EPC-EXs. After co-culturing the cells from different groups were incubated with DHE
solution (10 μM) for half an hour at 37°C. in dark. After 30 minutes, the solution was aspirated,
and using PBS the cells were washed twice. Fresh complete growth media was added, the cells
were observed under a fluorescence microscope, and using a flow cytometer percent DHE-positive
cells were analyzed.
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Cell viability analysis
SH-SY5Y neuronal cell viability was measured using MTT-(3- [4, 5-dimethylthiazyol-2yl]-2, 5diphenyltetrazolium bromide, 5 mg/mL, Sigma) assay. To determine the cell viability of the
neurons, SH-SY5Y cell lines were cultured in 96-well plates at a concentration of 2×103 cells/ well
and injured by subjecting them to hypoxic conditions for 6 hours; the cells were then re-oxygenated
for 24 hours, during the reoxygenation phase the neurons were co-cultured with different EPCEXs. After co-culturing the cells with exosomes, MTT solution (20 μL) was added and incubated
for 4 hours at 37°C. Later DMSO (150 μL) was added and incubated for 20 minutes at 37°C. On
a microplate reader (BioTek, USA) optical density was read at 490 nm. The percent cell viability
was calculated by comparing the relative absorbance of treated cells versus untreated cells.

Statistical analysis
All data are expressed as mean ± SD of at least 3-4 experiments. Using Student’s t-test
comparisons between two groups were performed, while one-way ANOVA was used for multiple
comparisons, followed by Tukey’s post hoc test. A value of P < 0.05 was considered statistically
significant. All the statistical analyses were performed using Prism GraphPad (version 9.0.2)
software.
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V. RESULTS

Exosomal release pattern and miR-210 released through the exosomes.
Upon culturing EPCs in complete growth (Cg) media and serum free (Sf) conditions, exosomes
were isolated, and concentration was determined by using NTA, we observed that EPCs cultured
in serum-free medium released more exosomes in comparison with cells grown in complete growth
media (*P<0.0001 vs Cg control/Cg miR-210 EPC-EXs, Fig 15A). This data is consistent with
previous studies from others and us that serum starvation could promote the release of EXs [50,51].
Moreover, the miR-210 levels are evaluated. We found that, the EPCs grown in complete growth
media had almost 50 times higher fold change in miR-210 levels in comparison with EPCs grown
in serum free media (*P<0.001 vs Cg/Sf control EPCs; #P<0.001 vs Sf-miR-210 EPCs, Fig 15B).
While in the isolated exosomes, it is found that exosomes isolated from the EPCs cultured in
complete growth media has very lower miR-210 expression (not even significant in comparison
with its control), than the exosomes isolated from serum free media (*P<0.001 vs Sf-control-EPCEXs, #P<0.001 vs Sf-miR-210-EPC-EXs, Fig 15C). This data further confirms that EPC-carried
miR-210 was transferred through their released exosomes. EPCs grown in complete growth media
tend to release very low concentration of exosomes as a result of transferring less mRNA from
cells to exosomes. Therefore, we observed higher miR-210 expression level in EPC than in their
released EXs. In case of EPCs grown in serum free media, they release a greater number of
exosomes as a result those cells tend to transfer more miR-210 into the exosomes, that is the reason
we tend to observe lower miR-210 expression in EPCs and higher miR-210 levels in EXs upon
serum starvation.
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A)
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B)

C)

Fig 15: Release pattern of EXs and miR-210 levels in EPCs and EXs before and after serum
starvation.
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A) The concentration of exosomes released from EPCs grown in complete growth media and
serum free media. Data represents mean ± SD, n = 4/ group (*P<0.0001 vs Cg control-EPCEXs/Cg miR-210 EPC-EXs). B) The miR-210 levels in EPCs before and after serum starvation.
Data represents mean ± SD, n = 4/ group (*P<0.001 vs Cg/Sf control EPCs; #P<0.001 vs Sf-miR210 EPCs). C) The miR-210 levels in EXs isolated from complete growth media and serum free
media. Data represents mean ± SD, n = 4/ group (P<0.001 vs Sf-control-EPC-EXs, #P<0.001 vs
Sf-miR-210-EPC-EXs).

Time course of exosome release and miR-210 level.
To evaluate the time-dependent effects of EXs release, we measured the EXs-concentration at
different time points under different situations (serum-free medium or complete medium). From
(Fig 16A) we can see that the exosome concentration is gradually increased as the time duration is
increased (*P <0.0001 vs C-EPC-EXs-24/C-EPC-EXs-12/C-EPC-EXs-6/miR-210-EPC-EXs24/miR-210-EPC-EXs12/miR-210-EPC-EXs-6). Evaluated miR-210 levels in both EPCs and EXs
at corresponding time point (Fig 16B, *P<0.05 vs control, #P<0.05 vs miR-210-EPC-24/ miR-210EPC-12/ miR-210-EPC-6; Fig 16C,*P<0.05 vs control, #P<0.05 vs miR-210-EPC-EXs-24/ miR210-EPC-EXs-12/ miR-210-EPC-EXs-6) we noticed that, with the increase in duration of serum
starvation in EPCs, the miR-210 levels are being decreased. Whereas in EXs with the increase
serum starvation duration there is a rise in both exosome release and miR-210 levels. This explains
that as the duration of serum starvation is increasing the cells tend to release more exosomes and
tend to transfer more miR-210, that is the reason we have observed reduction in miR-210 levels in
cells and rise in miR-210 levels in exosomes. Along with this we have observed that at 48 hours.
time point the exosomes release is at maximum level. In total, we have understood the flow of
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mRNA from cells to exosomes and also got to know that serum starving the EPCs for 48 hours.
helps in isolating high concentration of exosomes.

A)
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B)

C)

Fig 16: Time course of EXs release and miR-210 levels in EPCs and EXs.
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A) The data represents the EPC-EXs concentration at different duration of serum starvation. This
data is represented as mean ± SD, n=3/group, P <0.0001 vs C-EPC-EXs-24/C-EPC-EXs-12/CEPC-EXs-6/miR-210-EPC-EXs-24/miR-210-EPC-EXs12/miR-210-EPC-EXs-6.

B)

The

summarized data represent fold change in miR-210 levels in EPCs, subjected to different durations
of serum starvation. This data is represented as mean ± SD, n=3/group, *P<0.05 vs control,
#

P<0.05 vs miR-210-EPC-24/ miR-210-EPC-12/ miR-210-EPC-6. The data describes the fold

change in miR-210 levels in EPC-EXs that are isolated from EPCs subjected to different durations
of serum starvation This data is represented as mean ± SD, n=3/group, *P<0.05 vs control, #P<0.05
vs miR-210-EPC-EXs-24/ miR-210-EPC-EXs-12/ miR-210-EPC-EXs-6.

Transfecting EPCs with miR-210 mimic increases the level of miR-210 both in EPCs and
EPC-EXs.
To generate the miR-210 overexpressed EPC-EXs, the EPCs were transfected with miR-210
mimic, and then the EPC-EXs were isolated. By using qPCR, we have confirmed the miR-210
expression both in cells and EXs. The miR-210 expression in the miR-210 mimic transfected EPCs
was found to be about 50 folds significantly higher than the control and scramble transfected EPCs
(*P<0.0001 vs. Control/Scramble, Fig 17). In isolated EXs, it is found to be 25 folds significantly
higher than the EPCs-EXs isolated from control and scramble transfected groups ($P<0.001 vs.
Control/Scramble, Fig 18). This data suggest that miR-210 mimic could increase the level of miR210 in EPCs, which could be released through the EXs.

41

Fig 17: Level of miR-210 in EPCs after transfection.
The summarized data represents the fold change of the miR-210 expression in the EPCs transfected
with miR-210 mimic in comparison with un-transfected control and scramble transfected group.
This data is represented as mean ± SD, n=4/group, *P< ((0.05) vs. Control/Scramble).
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Fig 18: Level of miR-210 in EPC-EXs after transfection.
The summarized data represents the fold change in the miR-210 expression in the EPC-EXs that
are isolated from EPCs in different groups. The fold change in the level of miR-210 expression is
compared with the exosomes isolated from the un-transfected control and scramble transfected
group. This data is represented as mean ± SD, n=4/group, $P < (0.001) vs. Control/Scramble.

EPC-EXs were uptaken by neurons upon co-culturing.
To determine whether EPC-EXs could be uptaken by neurons, we co-incubated PKH 26-labeled
EPC-EXs with H/R injured neurons for 24 hours. Specifically, the neurons were cultured under
hypoxia for 6 hours and then the EPC-EXs were added to the neurons during the reoxygenation
phase for 24 hours. at a concentration of 2 x 1010 particle/ml. After co-incubation images (Fig 19A)
of neurons were taken and fluorescence was quantified by using Image J software. From the
images, we can see that PKH26-labeled EPC-EXs merged with the neurons as showing the red
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fluorescence in the cytoplasm of neurons. Upon measuring the fluorescence intensities (Fig 19B)
in all three groups there is no significant difference in the fluorescence intensities. This suggests
that the incorporation of EPC-EXs to the neurons and the loading of miR-210 into the exosomes
did not affect the incorporation rate to the neurons.
a)
A)
1a-c

2 a-c
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3a-c

B)

Fig 19: Uptake of EPC-EXs by H/R injured neurons upon coculturing for 24 hours.
A) Represents fluorescence images of PKH26-labeled EPC-EXs (red) merged with neurons. (1)
Blue: nucleus. (2) Red: PKH26 labeled EPC-EXs (3) overlay, Scale bar:100 µm. B) Summarized
data on the fluorescence intensities of incorporated EPC-EXs (red) in neurons. Images were
analyzed by using Image J software. Data represents mean ± SD, n = 4/ group.

miR-210-EPC-EXs significantly increased the miR-210 level in neurons upon co-culturing.
To evaluate whether miR-210-EPC-EXs could transfer miR-210 to neurons, the level of miR-210
in neurons was quantified by RT-PCR after co-incubation. As shown (Fig 20), the miR-210 level
in the neurons co-cultured with miR-210 EPC-EXs is almost 8-folds significantly higher than the
neurons co-cultured with EPC-EXs that are isolated from control and scramble transfected groups
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(*P (<0.05) vs. Control/Scramble). This data suggests miR-210- EPC-EXs can deliver miR-210 to
neurons after coculturing.

Fig 20: miR-210-EPC-EXs increase the miR-210 levels in neurons upon co-culturing.
The data represents the fold change in the miR-210 expression levels in neurons upon treating
them with different EPC-EXs. The level of miR-210 was measured by using the qRT-PCR. This
data is represented as mean ± SD, n=4/group, *P < (0.05) vs. Control/Scramble.
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miR-210-EPC-EXs were more effective than EPC-EXs in reducing H/R induced apoptosis in
neurons.
To evaluate the effect of EPC-EXs and miR-210-EPC-EXs on H/R-induced apoptosis in neurons,
we have co-cultured the neurons with different EXs for 24 hours., at a concentration of 2 x 1010
particle/ml. Using flow cytometry, the apoptosis percentage was determined (Annexin V+/ PIfocusing mainly on early apoptosis). The data (Fig 21) showed that H/R injury has significantly
elevated the apoptosis percentage in neurons (#P<0.001 vs. Control), which is partly reduced upon
treating with EPC-EXs and scramble-EPC-EXs (*P<0.001 vs. Vehicle; #P<0.001 vs. Control).
Moreover, we found that miR-210-EPC-EXs have almost completely attenuated the H/R induced
apoptosis in neurons (*P<0.001 vs. Vehicle; +P<0.001 vs. EPC-EXs/scramble-EPC-EXs). The
data implies that miR-210-EPC-EXs have an enhanced effect on protecting neurons from H/Rinduced apoptosis.

47

Fig 21: miR-210-EPC-EXs are more effective in decreasing H/R induced neuronal apoptosis.
The summarized data represents the apoptosis percentage in H/R injured neurons after treating
them with EXs. Data is represented as mean ± SD, n = 4/group, ( #P<0.001 vs. Control; *P<0.001
vs. vehicle; +P<0.001 vs. EPC-EXs/scramble-EPC-EXs).

Intracellular ROS generation in H/R injured neurons is attenuated more efficiently by miR210-EPC-EXs than EPC-EXs and scramble-EPC-EXs.
Elevated intracellular ROS levels are one of the most important factors for cell injury. To verify if
miR-210-EPC-EXs have elevated protective effects in reducing ROS levels in H/R neurons over
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EPC-EXs/scramble-EPC-EXs, we perform oxidative stress or intracellular ROS generation assay
24 hours. after co-culturing. In presence of ROS the superoxide indicator-DHE produces red
fluorescence in the neurons. The DHE-positive cells were detected using flow cytometry (Fig
22A), the images were captured by fluorescence microscope (Fig 22B) and the fluorescence
intensities were determined for each group (Fig 22C). The data (Fig 22A, B, and C) showed that
H/R injury has significantly elevated the ROS levels in neurons ( #P<0.001 vs. Control), which is
reduced to a certain extent upon treating with EPC-EXs and scramble-EPC-EXs (*P<0.001 vs.
Vehicle; #P<0.001 vs. Control). Moreover, we found that miR-210-EPC-EXs have profoundly
reduced the ROS levels in H/R neurons (*P<0.001 vs. Vehicle; +P<0.001 vs. EPC-EXs/scrambleEPC-EXs). This data demonstrates that miR-210-EPC-EXs are more capable than EPC-EXs and
scramble-EPC-EXs in reducing ROS levels in H/R neurons.
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A)

B)
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C)

Fig 22: Effect of miR-210-EPC-EXs on oxidative stress.
A) Summarized flow cytometry data representing DHE-positive cells. B) Represents images
obtained upon DHE staining. Red: ROS generated in neurons, Scale bar:100 µm C) Fluorescent
intensities of DHE stained neurons. Images were analyzed by using Image J software. Data
represents mean ± SD, n = 4/ group, (#P<0.001 vs. Control; *P<0.001 vs. vehicle; +P<0.001 vs.
EPC-EXs/scramble-EPC-EXs).
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miR-210-EPC-EXs are more effective in promoting cell viability in H/R injured neurons than
EPC-EXs and scramble-EPC-EXs.

To determine if miR-210 EPC-EXs could protect the neurons from H/R injury by increasing their
cell viability, we have co-cultured the H/R neurons with EXs for 24 hours., By using MTT assay
we have determined the neuronal cell viability. From the MTT data (Fig 23), we found that H/R
injury has significantly reduced the viable cell percentage ( #P<0.001 vs. Control), EPC-EXs and
scramble-EPC-EXs have significantly increased the cell viability (*P<0.001 vs. Vehicle; #P<0.001
vs. Control). A we expected, it is observed that miR-210-EPC-EXs are more efficient than EPCEXs and scramble-EPC-EXs in elevating neuronal cell viability (*P<0.001 vs. Vehicle; +P<0.001
vs. EPC-EXs/scramble-EPC-EXs).

Fig 23: miR-210-EPC-EXs are more effective in preserving cell viability in H/R injured
neurons.
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Summarized MTT data representing neuronal cell viability, the data implies that miR-210-EPCEXs promotes cell survival in H/R neurons. Data represents mean ± SD, n = 3/ group, (#P<0.001
vs. Control; *P<0.001 vs. vehicle; +P<0.001 vs. EPC-EXs/scramble-EPC-EXs).
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VI. DISCUSSION
In the present study, we investigated the beneficial effects of EPC-EXs and Scramble-EPC-EXs
on protecting the neurons from H/R-injury by reducing apoptosis, oxidative stress and by
increasing cell viability. Interestingly, we also found that the loading of miR-210 in EPC-EXs
boosted these protective effects.
we have reproduced the H/R injury model in cells, to investigate the protective effects of EPCEXs and miR-210 loaded EPC-EXs against H/R injury [46]. As we know, brain cells require a
sufficient amount of oxygen and glucose to generate ATP and maintain membrane potential for
normal functioning [4,5]. During ischemic stroke, as the artery that supplies blood to the brain is
blocked, the neurons do not receive blood supply properly and so they are oxygen-deprived. This
results in ATP level depletion and rises the intracellular calcium levels [3]. Which causes
mitochondrial injury, free radical generation, and finally damages the nucleus and, cell membrane.
Eventually leading to cell death [3,10,11]. As expected, H/R injury increased the neuronal
apoptosis, oxidative stress and eventually reduced the viability of neurons. This confirms the
success of the injury model.
EPCs have been shown to provide beneficial effects on ischemic stroke [29]. Our previous work
has reported that EPCs transfusion will reduce cerebral ischemic damage [47]. A study by Liao S
et al., demonstrated that EPCs have the ability to protect the neurons from ischemic injury by
repairing secretory functions and vascular endothelium [29]. Besides this EPCs are also known for
their angiogenesis, wound healing ability, and tissue regeneration [29]. The mechanism underlying
the therapeutic effects of EPCs could be from their differentiation to ECs to form new vessels, and
also from their released growth factors which promote angiogenesis and neurogenesis [29]. Most
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recent, research suggests that their released EXs could be one of the important contributors for
their beneficial effects [38].
EXs are the smallest extracellular vesicles, these lipid bilayer vesicles carry mRNA, miRNA,
DNA, lipids, proteins, and some components from the Golgi apparatus, mitochondria, endoplasmic
reticulum, and nucleus [30]. They are formed by the inward budding of endosomes and later
released into the extracellular space upon fusing with the plasma membrane [33,34]. They
communicate with other cells by docking and fusing. They play an important role in transferring
information from one cell to another also referred to as intercellular communication [39]. Along
with this EXs are known to possess a longer circulating half-life and they do not have a risk of
transplant rejection and aneuploidy all these postulates made exosomes the safest therapeutic tools
[38]. EXs derived from a variety of cell types such as embryonic stem cells, induced pluripotent
stem cells (iPSCs), adult stem cells such as mesenchymal stromal cells (MSCs), human umbilical
cord blood cells (HUCBCs), neural stem cells (NSCs), and EPCs have been employed to treat
ischemic stroke and other cerebrovascular diseases in pre-clinical studies [38]. Our previous
studies found that post-stroke inflammation can be alleviated by infusing EPC-EXs [49]. Ma,
Xiaotang, et al. found that EPC-EXs can protect endothelial cells from hypoxia and reoxygenation
injury by protecting mitochondrial functionality [48].
First of all, we determined the release pattern of EXs by culturing EPCs in different conditions.
Previous studies have shown that EXs release could be promoted upon different stimuli [50]. Here,
we compared the EXs release pattern upon culturing EPCs in complete growth media and serumfree conditions. Results stated that EXs release is higher under stress i.e., serum starvation (Fig
15A). This is consistent with the previous studies [50,51]. Moreover, we performed the time dependent effects of EXs release from EPCs. The data in Fig 16A explains that EXs release is
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gradually increased and reached the peak at 48 hours. time point. Basing this, in the present study
to achieve higher exosomal concentration, we have isolated the EXs from EPCs after 48 hours. of
serum starvation.
As we have discussed previously, EXs are lipid bilayer vesicles that can carry mRNA, miRNA,
DNA, lipids, proteins and have an important role in intercellular communication [38,39]. The
function of EXs is highly related to their carried molecules, they are known to convey the benefit
of one cell to another cell via microRNAs (miRNA) [39]. According to Bavelloni et al., 2020 miR210 is strongly linked with hypoxia pathway, in presence of any hypoxia-inducible factors miR210 gets upregulated. miR-210 is considered as master hypoxamir [43]. It influences cell survival
by targeting apoptotic genes and it has an antioxidant effect by reducing the production of reactive
oxygen species by mitochondria [43]. We have previously shown that neural progenitor cells
(NPC)-EXs alleviate endothelial oxidative stress and dysfunction through the miR-210
downstream Nox2 and VEGFR2 pathways [52]. miR-210 loaded EPC-EXs can protect endothelial
cells from hypoxia and reoxygenation injury by protecting mitochondrial functionality [48].
Considering these postulates of miR-210, in this study we evaluated the role of miR-210 in the
function of EPC-EXs on protecting neurons from H/R-induced injury. In order to raise the miR210 expression in EPC-EXs, we have transfected the EPCs with miR-210 mimic. The rise in miR210 level in EPCs is confirmed by qPCR (Fig 17). We also demonstrated the flow of mRNA from
cells to exosomes, Fig 16 B and C illustrates that with the increase in the duration of serum
starvation in EPCs, the miR-210 levels are being decreased. Whereas in EXs with the increased
serum starvation duration there is a rise in both exosome release and miR-210 levels. This explains
that as the duration of serum starvation is increasing the cells tend to release more exosomes and
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tend to transfer more miR-210, that is the reason we have observed a reduction in miR-210 levels
in cells and a rise in miR-210 levels in exosomes.
Meanwhile, upon co-incubating PKH 26-labeled EPC-EXs with neurons for 24 hours. we found
that (Fig 19A) the EPC-EXs have successfully incorporated into the neurons. And by comparing
the fluorescence intensities of the images it was clear that the loading of miR-210 into the
exosomes did not affect the incorporation rate to the neurons (Fig 19B). In addition to this, we
have quantified miR-210 levels in neurons. The data (Fig 20) explains that the miR-210 level in
the neurons co-cultured with miR-210 EPC-EXs is significantly higher than the neurons cocultured with EXs that are isolated from control and scramble transfected groups. This suggests
that miR-210- EPC-EXs can deliver miR-210 to neurons after coculturing.

Upon evaluating the functional effects of EPC-EXs on H/R injured neurons, we found that EPCEXs have significantly reduced the apoptosis percentage (Fig 21), ROS generation (Fig 22), and
finally increased the viability of neurons (Fig 23). In addition to this we found that miR-210-EPCEXs are efficient than EPC-EXs in reducing apoptosis percentage (Fig 21), oxidative stress (Fig
22) and also increases the percentage of the viable cells of neurons more significantly than EPCEXs (Fig 23).
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VII. CONCLUSION

Our study demonstrates that under stress EPCs tend to release EXs in higher concentrations and
the release of EXs is further increased with the increase in the duration of stress. During the course
of EXs release, the miR-210 from the EPCs is transferred to EXs. These stem cell-derived EXs
can be uptaken by the neurons and transports the miRNA from EPCs to neurons. Our results
demonstrate that miR-210 loading can enhance the protective effects of EPC-EXs on H/R induced
elevated apoptosis, oxidative stress and decreased the viability of neurons.
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VIII. FUTURE STUDIES

The significance of the present study is that the loading of miR-210 into EPC-EXs will boost the
protective effects of EPC-EXs against H/R injury in neurons. In the future by including a miR-210
inhibitor group might help us in confirming that, these enhanced effects are only due to miR-210.
we can extend this study by evaluating the effect of miR-210-EPC-EXs on mitochondrial fusion
/fission proteins and ATP generation in H/R neurons. It would be interesting if we can investigate
the mechanism existing behind these protective effects of miR-210.
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